NO20015078D0 - Sulfonamidderivater som har oksadiazolringer - Google Patents

Sulfonamidderivater som har oksadiazolringer

Info

Publication number
NO20015078D0
NO20015078D0 NO20015078A NO20015078A NO20015078D0 NO 20015078 D0 NO20015078 D0 NO 20015078D0 NO 20015078 A NO20015078 A NO 20015078A NO 20015078 A NO20015078 A NO 20015078A NO 20015078 D0 NO20015078 D0 NO 20015078D0
Authority
NO
Norway
Prior art keywords
sulfonamide derivatives
oxadiazole rings
oxadiazole
rings
sulfonamide
Prior art date
Application number
NO20015078A
Other languages
English (en)
Other versions
NO20015078L (no
Inventor
Fumihiko Watanabe
Yoshinori Tamura
Yasuhiko Fujii
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20015078D0 publication Critical patent/NO20015078D0/no
Publication of NO20015078L publication Critical patent/NO20015078L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20015078A 1999-04-19 2001-10-18 Sulfonamidderivater som har oksadiazolringer NO20015078L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11032199 1999-04-19
PCT/JP2000/002404 WO2000063194A1 (fr) 1999-04-19 2000-04-13 Derives de sulfonamide possedant des noyaux oxadiazole

Publications (2)

Publication Number Publication Date
NO20015078D0 true NO20015078D0 (no) 2001-10-18
NO20015078L NO20015078L (no) 2001-12-18

Family

ID=14532773

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015078A NO20015078L (no) 1999-04-19 2001-10-18 Sulfonamidderivater som har oksadiazolringer

Country Status (9)

Country Link
US (1) US6495578B1 (no)
EP (1) EP1172361A4 (no)
KR (1) KR20010113820A (no)
CN (1) CN1347411A (no)
AU (1) AU765203B2 (no)
CA (1) CA2367395A1 (no)
NO (1) NO20015078L (no)
PL (1) PL351374A1 (no)
WO (1) WO2000063194A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1270569A4 (en) 2000-01-26 2005-01-05 Shionogi & Co SUBSTITUTED TRYPTOPHAN DERIVATIVES
EP1288199A4 (en) 2000-04-28 2005-10-12 Shionogi & Co INHIBITORS OF MMP-12
US6657070B2 (en) 2000-12-13 2003-12-02 Wyeth Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
NZ538100A (en) 2000-12-13 2006-07-28 Arqule Inc Heterocyclic sulfonamide inhibitors of beta amyloid production
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
EE200300515A (et) * 2001-04-19 2004-02-16 Bayer Aktiengeshellschaft Arüülsulfoonamiidid kui viirusevastased ained
EP1406632A4 (en) * 2001-06-08 2009-11-04 Cytovia Inc 3-ARYL-5-ARYL-1,2,4-OXADIAZOLES AND THEIR ANALOGUES, CASPASE ACTIVATORS AND INDUCERS OF APOPTOSIS, AND USES THEREOF
EP1419767A4 (en) * 2001-08-20 2005-03-16 Ono Pharmaceutical Co MEDICINE FOR TREATMENT OF HEART FAILURE
JP4219810B2 (ja) * 2001-10-26 2009-02-04 塩野義製薬株式会社 Ｍｍｐ阻害作用を有するスルホンアミド誘導体
CN100364531C (zh) * 2002-12-18 2008-01-30 西托维亚公司 3,5－二取代－[1,2,4]－二唑及类似物和其用途
AU2003297232B2 (en) * 2002-12-20 2010-02-04 Merck Sharp & Dohme Corp. 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
AU2004230844B2 (en) 2003-03-31 2010-12-09 Wyeth Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
ES2537514T3 (es) 2003-04-04 2015-06-09 Incyte Corporation Composiciones, métodos y kits relacionados con la escisión de HER-2
JPWO2005012268A1 (ja) * 2003-07-30 2006-09-14 塩野義製薬株式会社 イソオキサゾール環を有するスルホンアミド誘導体
WO2005060961A2 (en) * 2003-12-18 2005-07-07 Astrazeneca Ab Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
US20080306124A1 (en) * 2005-06-08 2008-12-11 Rainer Albert Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands
DE102006009928A1 (de) 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
US8153166B2 (en) * 2006-06-08 2012-04-10 Chih-Hsiung Lin Composition for prophylaxis or treatment of urinary system infection and method thereof
RU2009115963A (ru) * 2006-09-29 2010-11-10 Новартис АГ (CH) Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами
WO2009029632A1 (en) 2007-08-27 2009-03-05 Helicon Therapeutics, Inc. Therapeutic isoxazole compounds
CN101896482B (zh) * 2007-12-10 2013-01-09 埃科特莱茵药品有限公司 作为s1p1/edg1激动剂的噻吩衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980009238A (ko) * 1995-07-28 1998-04-30 우에노 도시오 설포닐아미노산 유도체
KR100338857B1 (ko) * 1996-01-23 2002-05-30 시오노 요시히코 술폰화 아미노산 유도체 및 이를 함유한메탈로프로테이나제 저해제
PL186416B1 (pl) * 1996-05-17 2004-01-30 Warner Lambert Co Związek bifenylosulfonamidowy i preparat farmaceutyczny zawierający ten związek
AU2792097A (en) * 1996-05-24 1998-01-05 Ono Pharmaceutical Co. Ltd. Phenylsulfonamide derivatives
CZ16899A3 (cs) * 1996-07-22 1999-08-11 Monsanto Company Thiolsulfonamidové inhibitory metaloproteázy
SK262000A3 (en) * 1997-07-22 2001-01-18 Shionogi & Co Therapeutic or prophylactic agent for glomerulopathy
ES2862576T3 (es) 2011-09-16 2021-10-07 Amgen Inc Alimentación continúa controlada sin retroalimentación pre-programada de cultivos celulares

Also Published As

Publication number Publication date
EP1172361A4 (en) 2002-05-08
NO20015078L (no) 2001-12-18
WO2000063194A1 (fr) 2000-10-26
AU765203B2 (en) 2003-09-11
US6495578B1 (en) 2002-12-17
EP1172361A1 (en) 2002-01-16
KR20010113820A (ko) 2001-12-28
AU3677600A (en) 2000-11-02
CN1347411A (zh) 2002-05-01
CA2367395A1 (en) 2000-10-26
PL351374A1 (en) 2003-04-07

Similar Documents

Publication Publication Date Title
NO20015078L (no) Sulfonamidderivater som har oksadiazolringer
PT1175408E (pt) Derivados sulfonamida
DE50007817D1 (de) Mikrospiegel
NO20042673L (no) Acetylenderivaer som har mGluR5 antagonistisk aktivitet
NO20022888L (no) Lipopeptider som antibakterielle midler
NO20033618D0 (no) Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
ATE309998T1 (de) Pharmazeutisch wirksamer sulfonamid derivaten
NO20022887D0 (no) Lipopeptider som antibakterielle midler
DK1222192T3 (da) Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor
ID26829A (id) Turunan-turunan sulfonamida
DK1442030T3 (da) Thiopen- og thiazolsulfonamider som antineoplastiske midler
NO20022973L (no) Oksazolidinoner som har en sulfoksiminfunksjonalitet
ATE459598T1 (de) Sulfonamidderivate
ATE341544T1 (de) Sulfonamide
NO20043794L (no) Benzensulfonamidderivater som antipsykotiske midler
NO20030100D0 (no) Pleuromutilinderivater som har antibakteriell aktivitet
NO20012526D0 (no) Sammensetninger som innbefatter cefuroksimaksetil
DK1155013T3 (da) Heyterocycliske benzensulfonamidderivater som bradykininantagonister
NO20015668D0 (no) Substituerte imidazotiazoler som antidepressive midler
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
NO20013441D0 (no) Sammensetninger som har forbedret stabilitet
DE60024023D1 (de) Nockenwellenversteller
DZ3344A1 (fr) Derives de sulfonamide
DE69907845D1 (de) Sulfonamid-Derivate
DZ3343A1 (fr) Derives de sulfonamide

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application